Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteasome as an emerging therapeutic target in cancer.
Zavrski I, Kleeberg L, Kaiser M, Fleissner C, Heider U, Sterz J, Jakob C, Sezer O. Zavrski I, et al. Among authors: fleissner c. Curr Pharm Des. 2007;13(5):471-85. doi: 10.2174/138161207780162908. Curr Pharm Des. 2007. PMID: 17348844 Review.
Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion.
Zavrski I, Naujokat C, Niemöller K, Jakob C, Heider U, Langelotz C, Fleissner C, Eucker J, Possinger K, Sezer O. Zavrski I, et al. Among authors: fleissner c. J Cancer Res Clin Oncol. 2003 Jul;129(7):383-91. doi: 10.1007/s00432-003-0454-6. Epub 2003 Jul 8. J Cancer Res Clin Oncol. 2003. PMID: 12851815
Proteasome: an emerging target for cancer therapy.
Zavrski I, Jakob C, Schmid P, Krebbel H, Kaiser M, Fleissner C, Rosche M, Possinger K, Sezer O. Zavrski I, et al. Among authors: fleissner c. Anticancer Drugs. 2005 Jun;16(5):475-81. doi: 10.1097/00001813-200506000-00002. Anticancer Drugs. 2005. PMID: 15846112 Review.
Bortezomib inhibits human osteoclastogenesis.
von Metzler I, Krebbel H, Hecht M, Manz RA, Fleissner C, Mieth M, Kaiser M, Jakob C, Sterz J, Kleeberg L, Heider U, Sezer O. von Metzler I, et al. Among authors: fleissner c. Leukemia. 2007 Sep;21(9):2025-34. doi: 10.1038/sj.leu.2404806. Epub 2007 Jun 21. Leukemia. 2007. PMID: 17581612
Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.
Jakob C, Zavrski I, Heider U, Bollow M, Schulz CO, Fleissner C, Eucker J, Michael R, Hamm B, Possinger K, Sezer O. Jakob C, et al. Among authors: fleissner c. Clin Cancer Res. 2003 Aug 1;9(8):3047-51. Clin Cancer Res. 2003. PMID: 12912955
28 results